Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease

Elisa Cangiano, Caterina Cavazza, Gianluca Campo, Marco Valgimigli, Gloria Francolini, Patrizia Malagutti, Claudio Pratola, Roberto Ferrari

Research output: Contribution to journalArticle

Abstract

To test the role of necrosis, ischemia or both inbone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 ? cells and cytokines were evaluated at: T 0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T 3 and T 4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1a) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95%CI 2.2-4.2, P

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Thrombosis and Thrombolysis
Volume32
Issue number1
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Necrosis
Cardiovascular Diseases
Coronary Artery Disease
Ischemia
Unstable Angina
Vascular Endothelial Growth Factor A
Angiography
Bone Marrow
Myocardial Infarction
Cytokines
Control Groups

Keywords

  • Bone marrow cells
  • CD34 + cells
  • Cytokines
  • Stromal derived factor
  • Vascular endothelial factor

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Cangiano, E., Cavazza, C., Campo, G., Valgimigli, M., Francolini, G., Malagutti, P., ... Ferrari, R. (2011). Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. Journal of Thrombosis and Thrombolysis, 32(1), 1-8. https://doi.org/10.1007/s11239-010-0543-8

Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. / Cangiano, Elisa; Cavazza, Caterina; Campo, Gianluca; Valgimigli, Marco; Francolini, Gloria; Malagutti, Patrizia; Pratola, Claudio; Ferrari, Roberto.

In: Journal of Thrombosis and Thrombolysis, Vol. 32, No. 1, 07.2011, p. 1-8.

Research output: Contribution to journalArticle

Cangiano, E, Cavazza, C, Campo, G, Valgimigli, M, Francolini, G, Malagutti, P, Pratola, C & Ferrari, R 2011, 'Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease', Journal of Thrombosis and Thrombolysis, vol. 32, no. 1, pp. 1-8. https://doi.org/10.1007/s11239-010-0543-8
Cangiano, Elisa ; Cavazza, Caterina ; Campo, Gianluca ; Valgimigli, Marco ; Francolini, Gloria ; Malagutti, Patrizia ; Pratola, Claudio ; Ferrari, Roberto. / Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease. In: Journal of Thrombosis and Thrombolysis. 2011 ; Vol. 32, No. 1. pp. 1-8.
@article{fa59b12d13084689a97daad5724b22d8,
title = "Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease",
abstract = "To test the role of necrosis, ischemia or both inbone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 ? cells and cytokines were evaluated at: T 0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T 3 and T 4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1a) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95{\%}CI 2.2-4.2, P",
keywords = "Bone marrow cells, CD34 + cells, Cytokines, Stromal derived factor, Vascular endothelial factor",
author = "Elisa Cangiano and Caterina Cavazza and Gianluca Campo and Marco Valgimigli and Gloria Francolini and Patrizia Malagutti and Claudio Pratola and Roberto Ferrari",
year = "2011",
month = "7",
doi = "10.1007/s11239-010-0543-8",
language = "English",
volume = "32",
pages = "1--8",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease

AU - Cangiano, Elisa

AU - Cavazza, Caterina

AU - Campo, Gianluca

AU - Valgimigli, Marco

AU - Francolini, Gloria

AU - Malagutti, Patrizia

AU - Pratola, Claudio

AU - Ferrari, Roberto

PY - 2011/7

Y1 - 2011/7

N2 - To test the role of necrosis, ischemia or both inbone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 ? cells and cytokines were evaluated at: T 0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T 3 and T 4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1a) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95%CI 2.2-4.2, P

AB - To test the role of necrosis, ischemia or both inbone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 ? cells and cytokines were evaluated at: T 0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T 3 and T 4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1a) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95%CI 2.2-4.2, P

KW - Bone marrow cells

KW - CD34 + cells

KW - Cytokines

KW - Stromal derived factor

KW - Vascular endothelial factor

UR - http://www.scopus.com/inward/record.url?scp=80052471043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052471043&partnerID=8YFLogxK

U2 - 10.1007/s11239-010-0543-8

DO - 10.1007/s11239-010-0543-8

M3 - Article

C2 - 21197559

AN - SCOPUS:80052471043

VL - 32

SP - 1

EP - 8

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 1

ER -